Efficacy and Safety of TV-1380 for Facilitation of Abstinence in Cocaine-Dependent Subjects

- Cocaine Addiction
- Completed

Study Title: Efficacy and Safety of TV-1380 as Treatment for Facilitation of Abstinence in Cocaine-Dependent Subjects

Teva Identifier: TV1380-COA-201

ClinicalTrials.gov Identifier: NCT01887366

Study Status: Completed

Trial Condition(s): Cocaine Addiction

Interventions: Drug: TV-1380 150 mg | Drug: TV-1380 300 mg | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult

Age Range: 18 Years to 60 Years

Trial Duration: 06/01/2013 - 10/01/2014

Phase: Phase 2

Study Type

Interventional